Study results released this week show that an investigational drug, ocrelizumab, significantly reduces the progression of clinical disability in patients with primary progressive multiple sclerosis (PPMS).
Read More
Our providers work collaboratively and in a team-based structure. That means that you will be seeing a medical doctor (MD) and advanced practitioners, including physician assistants (PAs) and adult nurse…
The RMMSC’s education programs include seminars, classes and publications that reach throughout the Rocky Mountain region and beyond. Our long-running MS 101 program, the Conversations on MS series, semi-annual Education…
The Rocky Mountain MS Center at the University of Colorado is home to one of the largest MS research programs in the world. This unique partnership has created a world-class…
Here you will find a library of document resources. Click on title of document to open. Many documents are provided in PDF format and can be opened with the Adobe…
Getting the most out of your medical care may also involve the attention to some non-medical issues: Become an expert on your own insurance plan and identify someone in the…
Did you know that in terms of medication, multiple sclerosis is the second most expensive chronic disease to treat? Health-related costs average $57,500 per year with lifetime costs of more…
“In stressful times, we typically breathe too rapidly. This leads to a buildup of oxygen in the bloodstream and a corresponding decrease in the relative amount of carbon dioxide, which…
Disclosing that you have MS: According to the National MS Society, “The decision to disclose personal medical information in the workplace is a complex one, requiring careful thought and planning. Although…
Researchers from Taipei Medical University in Taiwan conducted a nationwide, population-based study to investigate the frequency and risk of MS following the occurrence of herpes zoster, the virus commonly known…